Effects of resistance exercise and whey protein intake in the treatment of sarcopenia

Effects of resistance exercise and whey protein intake in the treatment of sarcopenia - Treatment of sarcopenia, exercise, whey protein

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000043794

Enrollment

Registered

2021-04-01

Start date

2019-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sarcopenia

Interventions

Resistance exercise and whey protein intake Whey protein intake Resistance exercise

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Older adults with sarcopenia

Exclusion criteria

Exclusion criteria: Nutritional therapies for conditions such as type 2 diabetes and chronic kidney disease. Severe dementia, dysphagia, and joint disorders. Resistance training has been conducted twice a week for the past year. Non-sarcopenia.

Design outcomes

Primary

Measure	Time frame
Change of skeletal muscle mass index. Baseline, end of intervention, at 12 weeks of de-training, at 24 weeks of de-training	—

Secondary

Measure	Time frame
remission of sarcopenia. Change of grip strength, knee extension strength, gait speed. Baseline, end of intervention, at 12 weeks of de-training, at 24 weeks of de-training	—

Countries

Japan

Contacts

Public ContactHiroyasu Mori

Tokushima University Institute of Advanced Medical Sciences

mori.hiroyasu@tokushima-u.ac.jp0886337587

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026